ESC Premium Access

Systemic versus site targeted treatment of neoatherosclerosis.

Congress Presentation

About the speaker

Doctor Michael Joner

German Heart Center of Munich, Munich (Germany)
7 presentations
0 follower

4 more presentations in this session

Modeling the Individual Risk of Thrombosis in Oncology (MIRTO).

Speaker: Doctor J. Soria Fernandez (Sant Pau, ES)

Thumbnail

The importance of type of antithrombotic treatment after aortic valve replacement for the risk of future thromboembolic and bleeding events in aortic stenosis - Comparison of mechanical -, bio prosthetic and trans-catheter (TAVI) aortic valve replacement.

Speaker: Associate Professor C. Christersson (Uppsala, SE)

Thumbnail

Dual approach cardiac MRI for molecular assessment and interventional treatment of vulnerable coronary plaques in a porcine model.

Speaker: Doctor T. Heidt (Freiburg, DE)

Thumbnail

Identification of mirRNA profiles associated with venous thromboembolism and recurrent events (IMPROVEMENTS).

Speaker: Doctor D. Tregouet (Paris, FR)

Thumbnail

Access the full session

ESC Grants for Medical Research Innovation

Speakers: Doctor M. Joner, Doctor J. Soria Fernandez, Associate Professor C. Christersson, Doctor T. Heidt, Doctor D. Tregouet
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb